Search Ontology:
ChEBI

(2S,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-6-Carboxy-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid

Term ID
CHEBI:146968
Synonyms
  • 2-deoxy-2-sulfoamino-alpha-D-gluco-hexopyranosyl-(1->4)-alpha-L-ido-hexopyranosyluronic acid-(1->4)-2-deoxy-2-sulfoamino-alpha-D-gluco-hexopyranosyl-(1->4)-D-gluco-hexopyranuronic acid
  • GlcNS(a1-4)IdoA(a1-4)GlcNS(a1-4)GlcA
  • WURCS=2.0/3,4,3/[a2122A-1x_1-5][a2122h-1a_1-5_2*NSO/3=O/3=O][a2121A-1a_1-5]/1-2-3-2/a4-b1_b4-c1_c4-d1
Definition
References
  • GlyGen:G09372HW
  • GlyTouCan:G09372HW
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from (2S,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-6-Carboxy-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
Phenotype where environments contain (2S,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-6-Carboxy-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
Phenotype modified by environments containing (2S,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-6-Carboxy-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
Phenotype affecting (2S,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-6-Carboxy-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
Human Disease Model